ULTRAGENYX PHARMACEUTICAL

• ULTRAGENYX PHARMACEUTICAL INC. $1,570,000 In-house, the client's own filings · 6 filings
• MEHLMAN CONSULTING, INC. $360,000 Outside firm · 6 filings
• MILLER STRATEGIES, LLC $140,000 Outside firm · 3 filings
• AVIVA STRATEGIES (FKA MGB CONSULTING) $114,000 Outside firm · 5 filings
• ALPINE GROUP PARTNERS, LLC. $100,000 Outside firm · 3 filings
• FORBES-TATE $40,000 Outside firm · 3 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• HR 1262
  Mikaela Naylon Give Kids a Chance Act
  5 filings
• S 932
  Give Kids a Chance Act of 2025
  5 filings
• HR 1509
  Accelerating Kids’ Access to Care Act of 2025
  3 filings
• S 752
  Accelerating Kids’ Access to Care Act
  3 filings
• HR 1
  One Big Beautiful Bill Act
  2 filings
• HR 8646
  Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
  1 filing

• 2026 $1,230,000 14 filings
• 2025 $1,094,000 12 filings

• Health Issues 22
• Budget/Appropriations 7
• Medical/Disease Research/Clinical Labs 6
• Medicare/Medicaid 5
• Government Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 18
• SENATE 18
• Health & Human Services, Dept of (HHS) 6
• Office of Management & Budget (OMB) 4
• Food & Drug Administration (FDA) 2
• Centers For Medicare and Medicaid Services (CMS) 1
• Executive Office of the President (EOP) 1